Search

Author/Creator Fourneau, Nele

1. Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib study. (2020)

Authors:
Schaffer, Michael; Chaturvedi, Shalini; Davis, Cuc; de Jong, Jan; Aquino, Regina; Oki, Yasuhiro; Fourneau, Nele; Younes, Anas; Balasubramanian, Sriram
Journal:
Cancer treatment and research communications
Issue:
Number 25(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Quisinostat, bortezomib, and dexamethasone combination therapy for relapsed multiple myeloma. Issue 7 (2nd July 2016)

Authors:
Moreau, Philippe; Facon, Thierry; Touzeau, Cyrille; Benboubker, Lotfi; Delain, Martine; Badamo-Dotzis, Julie; Phelps, Charles; Doty, Christopher; Smit, Hans; Fourneau, Nele; Forslund, Ann; Hellemans, Peter; Leleu, Xavier
Journal:
Leukemia & lymphoma
Issue:
Volume 57:Issue 7(2016:Jul.)
Page Start:
1546
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study. Issue 2 (February 2019)

Authors:
Younes, Anas; Brody, Joshua; Carpio, Cecilia; Lopez-Guillermo, Armando; Ben-Yehuda, Dina; Ferhanoglu, Burhan; Nagler, Arnon; Ozcan, Muhit; Avivi, Irit; Bosch, Francesc; Caballero Barrigón, Maria Dolores; Hellmann, Andrzej; Kuss, Bryone; Ma, David D F; Demirkan, Fatih; Yağci, Münci; Horowitz, Neta...
Journal:
Lancet
Issue:
Volume 6:Issue 2(2019)
Page Start:
e67
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗